Basit öğe kaydını göster

dc.contributor.authorÇEBİ, CEREN
dc.contributor.authorSahmay, Sezai
dc.contributor.authorÖNCÜL, MAHMUT
dc.contributor.authorÖZÇİVİT, İPEK BETÜL
dc.contributor.authorBAŞIBÜYÜK, ZAFER
dc.date.accessioned2022-07-04T12:31:28Z
dc.date.available2022-07-04T12:31:28Z
dc.identifier.citationÖNCÜL M., ÖZÇİVİT İ. B. , BAŞIBÜYÜK Z., ÇEBİ C., Sahmay S., "Anti-Mullerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism", EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, cilt.273, ss.54-58, 2022
dc.identifier.issn0301-2115
dc.identifier.othervv_1032021
dc.identifier.otherav_20273f92-758c-4c2b-9f45-8cf0fbd46ad5
dc.identifier.urihttp://hdl.handle.net/20.500.12627/181893
dc.identifier.urihttps://doi.org/10.1016/j.ejogrb.2022.04.016
dc.description.abstractObjective: To determine the usefulness of Anti-Mullerian Hormone (AMH) and antral follicle count (AFC) as an ovarian reserve marker in hypogonadotropic hypogonadism (HH) patients and to find a limit value for the gonadotropin levels in the diagnosis of HH patients. Study design: It is a retrospective cross-sectional single-center study. One hundred ninety-nine women with HH and 171 healthy controls with no cycle disorders were included into this study. Continuous variables were expressed as mean +/- standard deviation. Statistical comparisons were carried out according to the intention to treat by Student's t-test, Mann-Whitney U test, where appropriate. Receiver operating characteristic curve-ROC was used to represent the sensitivity and specificity pair corresponding to decision threshold of FSH and LH levels in HH diagnosis. P < 0.05 was accepted to be statistically significant. Results: There was not any statistically significant difference between HH and control group regarding the age (23.94 +/- 6.56 vs. 23.92 +/- 3.01, respectively; p = 0.09). Serum AMH levels didn't show statistically significant difference between HH and control group (3.26 +/- 2.61 ng/mL vs. 3.15 +/- 1.46 ng/mL, respectively; p = 0.11). The difference of AFC between HH and control group was statistically significant (6.67 +/- 6.33 vs. 10.91 +/- 2.92, respectively; p < 0.001). Follicle-stimulating hormone (FSH), Luteinizing-hormone (LH) and Estradiol (E2) levels between the groups were found to be significantly different. Area under the receiver operating characteristic curve-ROC for FSH was 0.98 and for LH was 0.96. For the diagnosis of HH, FSH levels lower than 3.05 IU/L (with a sensitivity of 92% and specificity of 94%) and LH levels lower than 1.55 IU/L (with a sensitivity of 91% and specificity of 92%) can be used. Conclusion: In conclusion, serum AMH levels reflect the follicle cohort in HH cases validly with negligible underestimation of ovarian reserve. FSH < 3.05 IU/L and LH < 1.55 IU/L could be used with high sensitivity and specificity for the diagnosis of HH.
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectKADIN HASTALIKLARI & DOĞUM
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectÜREME BİYOLOJİSİ
dc.subjectBiyoloji ve Biyokimya
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectCerrahi Tıp Bilimleri
dc.subjectKadın Hastalıkları ve Doğum
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectObstetrics and Gynecology
dc.subjectBiochemistry (medical)
dc.titleAnti-Mullerian hormone, an ovarian reserve marker in hypogonadotropic hypogonadism
dc.typeMakale
dc.relation.journalEUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , Cerrahpaşa Tıp Fakültesi , Cerrahi Tıp Bilimleri Bölümü
dc.identifier.volume273
dc.identifier.startpage54
dc.identifier.endpage58
dc.contributor.firstauthorID3423965


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster